Instem Reports that Leading R&D Organizations are Deploying Cyto Study Manager & Cutting-Edge Flow-Cytometric Regulatory Genetox Testing Techniques CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a ...
The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as ...
MedPage Today on MSN
FDA proposes more flexibility in alternatives to animal testing in drug development
Non-animal testing methods could save drugmakers time and money, officials say ...
Clinicians are searching for quicker and easier collection methods and more accurate toxicology testing for infants affected by intrauterine substance exposure. Umbilical cord testing offers some ...
VANCOUVER, British Columbia, March 03, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or ...
Assessing the toxicity of food contaminants—including carcinogenic potential—is a major challenge in evaluating the risks associated with exposure. In recent years, as part of efforts to reduce animal ...
Chicago, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The global in-vitro toxicology testing market was valued at 26.00 billion in 2024 and is expected to reach US$ 57.55 billion by 2033, growing at a CAGR of ...
Detailed price information for Cannabix Techs Inc Ord (BLOZF) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results